CB Insights today named Ferrum Health to its ninth annual AI 100, showcasing the 100 most promising private artificial intelligence companies in the world.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
“This recognition reinforces the growing demand for trustworthy, clinically validated AI in healthcare,” said Pelu Tran, CEO and co-founder of Ferrum Health. “We’re proud to help leading health systems deploy AI with proper governance—bringing the promise of this technology into real-world care.”
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. Our research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. We also dug into Analyst Briefings submitted directly to us by startups.
Ferrum Health is redefining how health systems access and scale clinical AI by providing a secure, private AI platform that works across diverse IT environments—from on-prem infrastructure to private and public clouds. Ferrum Health partners with more than 200 facilities across the country – Sutter Health in Northern California (which includes 60,000 employees across 24 hospitals), Allina’s twelve hospitals in Minneapolis, The Hill Medical Corporation in the Los Angeles area, ARA Health Specialists in North Carolina, Radiology Associates of Albuquerque, Carle Health’s network of 1,300 doctors, and more. With a rapidly expanding marketplace of pre-vetted clinical AI tools, Ferrum Health enables these hospitals to evaluate and deploy algorithms in days rather than months.
Quick facts on the 2025 AI 100:
- The 100 winners include 21 startups in AI agent platforms and infrastructure, 12 in AI observability and governance, and 12 in physical AI technology and building blocks.
- The 2025 cohort is deploying AI across horizontal applications (customer service, process automation), infrastructure (AI observability, AI agent building), and verticals (healthcare and life sciences, industrials, financial services).
- Collectively, these companies have raised $11.4B in equity funding over time, including more than $2.3B in 2025 (as of 4/16/2025).
- Nearly 75% are early-stage companies (Series A or earlier).
- 27 companies are based outside the United States, spanning 13 countries. This includes companies in developing and competitive AI markets like France and South Korea.
- The cohort has formed 315+ business relationships since 2023, including with industry leaders like NVIDIA, Google, and Uber.
About CB Insights
CB Insights is an AI super analyst for market intelligence. It delivers instant insights that help you bet on the right markets, track competitors, and source the right companies. Our AI super analyst is powerful because it is built on the validated database of companies and markets that CB Insights is famous for. To learn more, please visit www.cbinsights.com.
About Ferrum Health
Ferrum Health is a privately deployed, enterprise AI platform helping health systems discover, validate, and deploy clinical AI tools at scale. By enabling seamless integration of AI solutions across on-premises, private cloud, and cloud environments, Ferrum Health empowers healthcare organizations to enhance care quality, optimize workflows, and improve patient outcomes.